BRIEF-Yesway Announces IPO Of Class A Common Stock-March 2024-www.financetom.com

BRIEF-Yesway Announces IPO Of Class A Common Stock

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Yesway Announces IPO Of Class A Common Stock

Mar 27, 2026 12:37 PM

March 27 (Reuters) - Yesway Inc:

* YESWAY INC - ANNOUNCES INITIAL PUBLIC OFFERING OF CLASS A

COMMON STOCK - SEC FILING

* YESWAY INC - APPLIES TO LIST CLASS A COMMON STOCK ON

NASDAQ UNDER SYMBOL 'YSWY' - SEC FILING

* YESWAY INC: KEYBANC CAPITAL MARKETS, GUGGENHEIM

SECURITIES, RAYMOND JAMES ARE AMONG UNDERWRITERS TO IPO- SEC

FILING

* YESWAY INC: MORGAN STANLEY, J.P. MORGAN, GOLDMAN SACHS &

CO. LLC, BARCLAYS, BMO CAPITAL MARKETS ARE UNDERWRITERS TO IPO -

SEC FILING

Source text:

Further company coverage:

Previous page： Procter & Gamble Insider Sold Shares Worth $3,089,880, According to a Recent SEC Filing Next page： Eli Lilly Expands Zepbound Vial Dose Options, Cuts Weight-Loss Drug's Prices for Self-Pay Patients

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Procter & Gamble Insider Sold Shares Worth $3,089,880, According to a Recent SEC Filing

Feb 25, 2025

01:53 PM EST, 02/25/2025 (MT Newswires) -- Gary A Coombe, CEO, Grooming, on February 25, 2025, sold 18,000 shares in Procter & Gamble ( PG ) for $3,089,880. Following the Form 4 filing with the SEC, Coombe has control over a total of 23,816 common shares of the company, with 22,051 shares held directly and 1,765 controlled indirectly. SEC Filing:...

Eli Lilly Expands Zepbound Vial Dose Options, Cuts Weight-Loss Drug's Prices for Self-Pay Patients

Feb 25, 2025

01:57 PM EST, 02/25/2025 (MT Newswires) -- Eli Lilly ( LLY ) on Tuesday launched higher doses of Zepbound, or tirzepatide, in single-dose vials and reduced the prices of two smaller doses of the weight-loss drug for self-pay patients. The pharmaceutical giant said the new 7.5-milligram and 10 mg vials are available for $499 a month under a new self...

MGE Energy's Q4 Earnings, Revenue Rise

Feb 25, 2025

01:46 PM EST, 02/25/2025 (MT Newswires) -- MGE Energy ( MGEE ) reported Q4 earnings Tuesday of $0.61 per diluted share, up from $0.55 per share a year earlier. A single analyst polled by FactSet expected $0.84 per share. Operating revenue for the quarter ended Dec. 31 was $171.4 million up from $164.7 million a year earlier. Analyst estimates weren't...

Datadog Unusual Options Activity

Feb 25, 2025

Investors with a lot of money to spend have taken a bullish stance on Datadog ( DDOG ) . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big...